These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 9035226)

  • 1. What happens to patients after the end of a clinical trial? Systematic follow-up observational study of an open moclobemide trial in major depression.
    Linden M; Baier D; Gothe H; Kohnen R
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):35-43. PubMed ID: 9035226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social phobia: long-term treatment outcome and prediction of response--a moclobemide study.
    Versiani M; Amrein R; Montgomery SA
    Int Clin Psychopharmacol; 1997 Sep; 12(5):239-54. PubMed ID: 9466158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Moclobemide in the long-term treatment of depressed patients].
    Carl G; Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():48-50. PubMed ID: 2511580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
    Becker T; Struck M; Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
    Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Customary antidepressive treatment in Hungary: moclobemid therapy in everyday practice].
    Bartkó G
    Orv Hetil; 1997 Sep; 138(37):2341-5. PubMed ID: 9340582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary experience with moclobemide for the treatment of depressive disorders in Malaysia.
    Indran SK
    Singapore Med J; 1995 Apr; 36(2):189-90. PubMed ID: 7676265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
    Ramasubbu R
    J Psychiatry Neurosci; 1999 Jan; 24(1):45-50. PubMed ID: 9987207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of atypical depression with moclobemide: a sequential double controlled study.
    Schweitzer I; Tiller J; Maguire K; Davies B
    Int J Clin Pharmacol Res; 1989; 9(2):111-7. PubMed ID: 2654034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP; Tsoi WF
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression.
    Bakish D; Wiens A; Ellis J; Alda M; Lapierre Y
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-monitoring of psychotropic drug therapy in post-marketing surveillance. Results of a drug utilization observation (DUO) study on moclobemide.
    Laux G; Baier D
    Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):21-7. PubMed ID: 9035224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
    Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L
    J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Moclobemide in the treatment of depression--an overview].
    Laux G
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():37-40. PubMed ID: 2685855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression.
    Botte L; Evrard JL; Gilles C; Stenier P; Wolfrum C
    Acta Psychiatr Belg; 1992; 92(6):355-69. PubMed ID: 1345409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
    König F; Wolfersdorf M
    Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moclobemide in continuation treatment of major depressive episodes: an open follow-up study over six months.
    Gagiano CA; Müller FG; de Kock RF; Schall R
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):46S-50S. PubMed ID: 7593731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moclobemide for depression: an Australian psychiatric practice study.
    Tiller JW; Johnson GF; Burrows GD
    J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):31S-34S. PubMed ID: 7593727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.